Contact
searchSearch
HMP Global
Login
Infographic

Subcutaneous Immuno-Oncology for Metastatic Melanoma: Clinical Context, Patient Value, and Practice Implementation

06/11/2026

Explore key considerations in metastatic melanoma treatment selection, including factors beyond efficacy that can affect the patient experience.

© 2026 HMP Global. All Rights Reserved.

Related Content

Thumbnail
Special Article
Subcutaneous Immuno-Oncology in Metastatic Melanoma: Evolving Treatment Delivery Beyond Efficacy
06/11/2026
Review the current immuno-oncology treatment landscape in metastatic melanoma and considerations that can influence treatment selection.
Review the current immuno-oncology treatment landscape in metastatic melanoma and considerations that can influence treatment selection.
Review the current...
06/11/2026
Oncology
Thumbnail
Videos
How to Implement Subcutaneous Immuno-Oncology for Providers
06/11/2026
Roxana Dronca, MD; Samantha Guild, JD; Jennifer Hunze, MSN, RN; Lucia Nolan, PharmD
Experts discuss practical considerations for implementing subcutaneous immunotherapy in melanoma care, including workflow integration, operational planning, and patient access.
Experts discuss practical considerations for implementing subcutaneous immunotherapy in melanoma care, including workflow integration, operational planning, and patient access.
Experts discuss practical...
06/11/2026
Oncology
Thumbnail
Videos
Advantages of Subcutaneous Immuno-Oncology for Patients
06/11/2026
Roxana Dronca, MD; Samantha Guild, JD; Jennifer Hunze, MSN, RN; Lucia Nolan, PharmD
Experts discuss the patient-centered advantages of subcutaneous immunotherapy for melanoma, including reduced treatment time and greater flexibility in care delivery.
Experts discuss the patient-centered advantages of subcutaneous immunotherapy for melanoma, including reduced treatment time and greater flexibility in care delivery.
Experts discuss the...
06/11/2026
Oncology
Thumbnail
Videos
Subcutaneous Immuno-Oncology Options Available for Metastatic Melanoma
06/11/2026
Roxana Dronca, MD; Samantha Guild, JD; Jennifer Hunze, MSN, RN; Lucia Nolan, PharmD
Experts review the evidence supporting subcutaneous immunotherapy options for melanoma and discuss how pharmacokinetic, efficacy, and safety data inform their use in clinical practice.
Experts review the evidence supporting subcutaneous immunotherapy options for melanoma and discuss how pharmacokinetic, efficacy, and safety data inform their use in clinical practice.
Experts review the evidence...
06/11/2026
Oncology

More in This Series:

Thumbnail
Infographic
Subcutaneous Immuno-Oncology for Metastatic Melanoma: Clinical Context, Patient Value, and Practice Implementation
06/11/2026
Explore key considerations in metastatic melanoma treatment selection, including factors beyond efficacy that can affect the patient experience.
Explore key considerations in metastatic melanoma treatment selection, including factors beyond efficacy that can affect the patient experience.
Explore key considerations in...
06/11/2026
Oncology
Thumbnail
Special Article
Subcutaneous Immuno-Oncology in Metastatic Melanoma: Evolving Treatment Delivery Beyond Efficacy
06/11/2026
Review the current immuno-oncology treatment landscape in metastatic melanoma and considerations that can influence treatment selection.
Review the current immuno-oncology treatment landscape in metastatic melanoma and considerations that can influence treatment selection.
Review the current...
06/11/2026
Oncology
Thumbnail
Videos
How to Implement Subcutaneous Immuno-Oncology for Providers
06/11/2026
Roxana Dronca, MD; Samantha Guild, JD; Jennifer Hunze, MSN, RN; Lucia Nolan, PharmD
Experts discuss practical considerations for implementing subcutaneous immunotherapy in melanoma care, including workflow integration, operational planning, and patient access.
Experts discuss practical considerations for implementing subcutaneous immunotherapy in melanoma care, including workflow integration, operational planning, and patient access.
Experts discuss practical...
06/11/2026
Oncology
Thumbnail
Videos
Advantages of Subcutaneous Immuno-Oncology for Patients
06/11/2026
Roxana Dronca, MD; Samantha Guild, JD; Jennifer Hunze, MSN, RN; Lucia Nolan, PharmD
Experts discuss the patient-centered advantages of subcutaneous immunotherapy for melanoma, including reduced treatment time and greater flexibility in care delivery.
Experts discuss the patient-centered advantages of subcutaneous immunotherapy for melanoma, including reduced treatment time and greater flexibility in care delivery.
Experts discuss the...
06/11/2026
Oncology
Thumbnail
Videos
Subcutaneous Immuno-Oncology Options Available for Metastatic Melanoma
06/11/2026
Roxana Dronca, MD; Samantha Guild, JD; Jennifer Hunze, MSN, RN; Lucia Nolan, PharmD
Experts review the evidence supporting subcutaneous immunotherapy options for melanoma and discuss how pharmacokinetic, efficacy, and safety data inform their use in clinical practice.
Experts review the evidence supporting subcutaneous immunotherapy options for melanoma and discuss how pharmacokinetic, efficacy, and safety data inform their use in clinical practice.
Experts review the evidence...
06/11/2026
Oncology

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use